Document:

<PAGE>
                                                                     EXHIBIT 4.5
                                        EXHIBIT B (AS AMENDED ON APRIL 10, 2003)

                                                                    NO. CW - ___

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "ACT"), OR UNDER THE SECURITIES LAWS OF ANY STATE.
THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND
MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE ACT AND
APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION
THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN
FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY
PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE ACT AND ANY APPLICABLE
STATE SECURITIES LAWS.

                           WARRANT TO PURCHASE SHARES
                               OF COMMON STOCK OF
                       INTRABIOTICS PHARMACEUTICALS, INC.
                            (VOID AFTER MAY 1, 2008)

      This certifies that_______________, or its permitted assigns (the
"Holder"), for value received, is entitled to purchase from INTRABIOTICS
PHARMACEUTICALS, INC., a Delaware corporation (the "Company"), having a place of
business at 2483 East Bayshore Road, Suite 100, Palo Alto, California 94303,
such aggregate maximum number of fully paid and nonassessable shares of the
Company's Common Stock ("Common Stock") as would be obtained in accordance with
the formula set forth below at a price equal to the Stock Purchase Price (as
defined below) at any time or from time to time, subject to Section 1.1 hereof,
up to and including 5:00 p.m. (Pacific time) on May 1, 2008 (the "Expiration
Date") upon surrender to the Company at its principal office (or at such other
location as the Company may advise the Holder in writing) of this Warrant
properly endorsed with the Form of Subscription attached hereto duly filled in
and signed and upon payment in cash or wire transfer of the aggregate Stock
Purchase Price for the number of shares for which this Warrant is being
exercised determined in accordance with the provisions hereof. The aggregate
number of shares subject to this Warrant shall be equal to (i) 50% of the
Holder's aggregate purchase price for the shares of Series A Convertible
Preferred Stock (the "Series A Preferred") as set forth on the Signature Page
(as defined therein) of that certain Preferred Stock and Warrant Purchase
Agreement (the "Purchase Agreement"), dated as of February 5, 2003 (the
"Definitive Agreement Date"), between the Holder and the Company divided by (ii)
ninety-two percent (92%) of the Stock Purchase Price. The "Stock Purchase Price"
shall initially be equal to the lesser of (i) the average of the closing sale
prices of the Common Stock on The Nasdaq National Market for the five (5)
trading days immediately preceding and ending on the last trading day prior to
the Definitive Agreement Date and (ii) the average of the closing sale prices of
the Common Stock on The Nasdaq National Market for the five (5) trading days
immediately preceding and ending on the last trading day prior to the Company's
stockholders meeting at which the issuance of the Series A Preferred is

                                       1.
<PAGE>
approved; provided, however, that if the Company has not effected a reverse
stock split of the Company's outstanding Common Stock within the range of
1-for-8 to 1-for 12 (the "Reverse Split") at least three (3) trading days prior
to the beginning of the five (5) trading day range described in clause (ii)
immediately above, then such five (5) trading day range shall not commence until
the date that is the fourth trading day after the effectiveness of the Reverse
Split; provided further, that notwithstanding anything set forth herein to the
contrary, in the event that the total number of shares of Series A Preferred (on
an as-is-converted basis) issued or issuable pursuant to the Purchase Agreement
is subject to the limitation of no greater than 19.9% of the Company's issued
and outstanding shares of Common Stock on the date of the Purchase Agreement (in
accordance with the requirements of The Nasdaq Stock Market for purposes of Rule
4350(i)(1)(D) thereof), then the Stock Purchase Price shall be equal to the
closing bid price of the Common Stock on The Nasdaq Stock Market on the
Definitive Agreement Date. The Stock Purchase Price and the number of shares
purchasable hereunder are subject to adjustment as provided in Section 3 of this
Warrant. As used herein, the term "Original Issue Date" shall mean the issuance
date of this Warrant.

      This Warrant is subject to the following terms and conditions:

      1. EXERCISE; ISSUANCE OF CERTIFICATES; PAYMENT FOR SHARES.

            1.1 GENERAL. This Warrant is exercisable at the option of the Holder
of record hereof, at any time or from time to time, up to the Expiration Date
for all or any part of the shares of Common Stock (but not for a fraction of a
share) which may be purchased hereunder; provided, however, that notwithstanding
anything set forth herein to the contrary, in the event that the total number of
shares of Series A Preferred (on an as-is-converted basis) issued or issuable
pursuant to the Purchase Agreement is subject to the limitation of no greater
than 19.9% of the Company's issued and outstanding shares of Common Stock on the
date of the Purchase Agreement (in accordance with the requirements of The
Nasdaq Stock Market for purposes of Rule 4350(i)(1)(D) thereof), then this
Warrant shall not be exercisable until after the six (6) months anniversary of
the Original Issue Date. The Company agrees that the shares of Common Stock
purchased under this Warrant shall be and are deemed to be issued to the Holder
hereof as the record owner of such shares as of the close of business on the
date on which this Warrant shall have been surrendered, properly endorsed, the
completed, executed Form of Subscription delivered and payment made for such
shares. Certificates for the shares of Common Stock so purchased, together with
any other securities or property to which the Holder hereof is entitled upon
such exercise, shall be delivered to the Holder hereof by the Company at the
Company's expense within a reasonable time after the rights represented by this
Warrant have been so exercised. In case of a purchase of less than all the
shares which may be purchased under this Warrant, the Company shall cancel this
Warrant and execute and deliver a new Warrant or Warrants of like tenor for the
balance of the shares purchasable under the Warrant surrendered upon such
purchase to the Holder hereof within a reasonable time. Each stock certificate
so delivered shall be in such denominations of Common Stock as may be requested
by the Holder hereof and shall be registered in the name of such Holder or in
the name of Holder's affiliate and/or subsidiary as may be requested by the
Holder.

                                       2.
<PAGE>
      1.2 NET ISSUE EXERCISE. Notwithstanding any provisions herein to the
contrary, if the fair market value of one share of the Company's Common Stock is
greater than the Stock Purchase Price (at the date of calculation as set forth
below), in lieu of exercising this Warrant for cash, the Holder may elect to
receive shares equal to the value (as determined below) of this Warrant (or the
portion thereof being canceled) by surrender of this Warrant at the principal
office of the Company together with the properly endorsed Form of Subscription
with notice of such election in which event the Company shall issue to the
Holder a number of shares of Common Stock computed using the following formula:

                           X = Y (A-B)
                                 -----
                                   A

      Where X = the number of shares of Common Stock to be issued to the Holder

                           Y = the number of shares of Common Stock purchasable
                           under the Warrant or, if only a portion of the
                           Warrant is being exercised, the portion of the
                           Warrant being canceled (at the date of such
                           calculation)

                           A = the fair market value of one share of the
                           Company's Common Stock (at the date of such
                           calculation)

                           B = Stock Purchase Price (as adjusted to the date of
                           such calculation)

      For purposes of the above calculation, if the Common Stock is traded on
any established stock exchange or traded on the Nasdaq National Market or the
Nasdaq SmallCap Market, then the fair market value of one share of Common Stock
shall be the closing sales price for such stock (or the closing bid, if no sales
were reported) as quoted on such exchange or market (or the exchange or market
with the greatest volume of trading in the Common Stock) on the last market
trading day prior to the day of determination, as reported in The Wall Street
Journal or, if not reported in The Wall Street Journal, then such other source
as the Company's Board of Directors reasonably deems reliable. In the absence of
such markets for Common Stock, the fair market value of one share of Common
Stock shall be determined by the Company's Board of Directors in good faith.

      2. SHARES TO BE FULLY PAID; RESERVATION OF SHARES. The Company covenants
and agrees that all shares of Common Stock which may be issued upon the exercise
of the rights represented by this Warrant will, upon issuance, be duly
authorized, validly issued, fully paid and nonassessable and free from all
preemptive rights of any stockholder and free of all taxes, liens and charges
with respect to the issue thereof. The Company further covenants and agrees
that, during the period within which the rights represented by this Warrant may
be exercised, the Company will at all times have authorized and reserved, for
the purpose of issue or transfer upon exercise of the subscription rights
evidenced by this Warrant, a sufficient number of shares of authorized but
unissued Common Stock, or other securities and property, when and as required to
provide for the exercise of the rights represented by this Warrant. The Company
will take all

                                       3.
<PAGE>
such action as may be necessary to assure that such shares of Common Stock may
be issued as provided herein without violation of any applicable law or
regulation, or of any requirements of any securities exchange upon which the
Common Stock may be listed; provided, however, that, except as required by the
Purchase Agreement, the Company shall not be required to effect a registration
under federal or state securities laws solely because of such exercise. The
Company will not take any action which would result in any adjustment of the
Stock Purchase Price (as set forth in Section 3 hereof) if the total number of
shares of Common Stock issuable after such action upon exercise of all
outstanding warrants, together with all shares of Common Stock then outstanding
and all shares of Common Stock then issuable upon exercise of all options and
upon the conversion of all convertible securities then outstanding, would exceed
the total number of shares of Common Stock then authorized by the Company's
Certificate of Incorporation.

      3. ADJUSTMENT OF STOCK PURCHASE PRICE AND NUMBER OF SHARES. The Stock
Purchase Price and the number of shares purchasable upon the exercise of this
Warrant shall be subject to adjustment from time to time upon the occurrence of
certain events described in this Section 3. Upon each adjustment of the Stock
Purchase Price, the Holder of this Warrant shall thereafter be entitled to
purchase, at the Stock Purchase Price resulting from such adjustment, the number
of shares obtained by multiplying the Stock Purchase Price in effect immediately
prior to such adjustment by the number of shares purchasable pursuant hereto
immediately prior to such adjustment, and dividing the product thereof by the
Stock Purchase Price resulting from such adjustment.

            3.1 SUBDIVISION OR COMBINATION OF STOCK. In case the Company shall
at any time subdivide its outstanding shares of Common Stock into a greater
number of shares, the Stock Purchase Price in effect immediately prior to such
subdivision shall be proportionately reduced, and conversely, in case the
outstanding shares of Common Stock of the Company shall be combined into a
smaller number of shares, the Stock Purchase Price in effect immediately prior
to such combination shall be proportionately increased.

            3.2 DIVIDENDS IN COMMON STOCK, OTHER STOCK, PROPERTY,
RECLASSIFICATION. If at any time or from time to time the holders of Common
Stock (or any shares of stock or other securities at the time receivable upon
the exercise of this Warrant) shall have received or become entitled to receive,
without payment therefor,

                  (A) Common Stock or any shares of stock or other securities
which are at any time directly or indirectly convertible into or exchangeable
for Common Stock, or any rights or options to subscribe for, purchase or
otherwise acquire any of the foregoing by way of dividend or other distribution,

                  (B) any cash paid or payable otherwise than as a cash
dividend, or

                  (C) Common Stock or additional stock or other securities or
property (including cash) by way of spinoff, split-up, reclassification,
combination of shares or similar corporate rearrangement, (other than shares of
Common Stock issued as a stock split or adjustments in respect of which shall be
covered by the terms of Section 3.1 above),

                                       4.
<PAGE>
                  then and in each such case, the Holder hereof shall, upon the
exercise of this Warrant, be entitled to receive, in addition to the number of
shares of Common Stock receivable thereupon, and without payment of any
additional consideration therefor, the amount of stock and other securities and
property (including cash in the cases referred to in clauses (b) and (c) above)
which such Holder would hold on the date of such exercise had he been the holder
of record of such Common Stock as of the date on which holders of Common Stock
received or became entitled to receive such shares or all other additional stock
and other securities and property.

            3.3 REORGANIZATION, RECLASSIFICATION, CONSOLIDATION, MERGER OR SALE.
If any recapitalization, reclassification or reorganization of the capital stock
of the Company, or any consolidation or merger of the Company with another
corporation, or the sale of all or substantially all of its assets or other
transaction shall be effected in such a way that holders of Common Stock shall
be entitled to receive stock, securities, or other assets or property (an
"Organic Change"), then, as a condition of such Organic Change, lawful and
adequate provisions shall be made by the Company whereby the Holder hereof shall
thereafter have the right to purchase and receive (in lieu of the shares of the
Common Stock of the Company immediately theretofore purchasable and receivable
upon the exercise of the rights represented hereby) such shares of stock,
securities or other assets or property as may be issued or payable with respect
to or in exchange for a number of outstanding shares of such Common Stock equal
to the number of shares of such stock immediately theretofore purchasable and
receivable upon the exercise of the rights represented hereby. In the event of
any Organic Change, appropriate provision shall be made by the Company with
respect to the rights and interests of the Holder of this Warrant to the end
that the provisions hereof (including, without limitation, provisions for
adjustments of the Stock Purchase Price and of the number of shares purchasable
and receivable upon the exercise of this Warrant) shall thereafter be
applicable, in relation to any shares of stock, securities or assets thereafter
deliverable upon the exercise hereof. The Company will not effect any such
consolidation, merger or sale unless, prior to the consummation thereof, the
successor corporation (if other than the Company) resulting from such
consolidation or merger or the corporation purchasing such assets shall assume
by written instrument the obligation to deliver to such Holder such shares of
stock, securities or assets as, in accordance with the foregoing provisions,
such Holder may be entitled to purchase.

            3.4 CERTAIN EVENTS. If any change in the outstanding Common Stock of
the Company or any other event occurs as to which the other provisions of this
Section 3 are not strictly applicable or if strictly applicable would not fairly
protect the purchase rights of the Holder of the Warrant in accordance with such
provisions, then the Board of Directors of the Company shall make an adjustment
in the number and class of shares available under the Warrant, the Stock
Purchase Price or the application of such provisions, so as to protect such
purchase rights as aforesaid. The adjustment shall be such as will give the
Holder of the Warrant upon exercise for the same aggregate Stock Purchase Price
the total number, class and kind of shares as such Holder would have owned had
the Warrant been exercised prior to the event and had such Holder continued to
hold such shares until after the event requiring adjustment.

                                       5.
<PAGE>
            3.5 NOTICES OF CHANGE.

                  (A) Immediately upon any adjustment in the number or class of
shares subject to this Warrant and of the Stock Purchase Price, the Company
shall give written notice thereof to the Holder, setting forth in reasonable
detail and certifying the calculation of such adjustment.

                  (B) The Company shall give written notice to the Holder at
least ten (10) calendar days prior to the date on which the Company closes its
books or takes a record for determining rights to receive any dividends or
distributions or any right to subscribe for, purchase or otherwise acquire any
shares of stock of any class or any other securities or property, or to receive
any other right.

                  (C) The Company shall give written notice to the Holder at
least ten (10) calendar days prior to the date on which an Organic Change shall
take place, including in such notice the date as of which the Organic Change is
expected to become effective and the date as of which it is expected that
holders of Common Stock of record shall be entitled to exchange their shares of
Common Stock for securities or other property, if any, deliverable upon such
Organic Change.

                  (D) The Company shall initiate the delivery of written notice
to the Holder of any voluntary or involuntary dissolution, liquidation or
winding-up of the Company (the "Dissolution") on the date such Dissolution is
publicly announced, including in such notice the date as of which the
Dissolution is expected to become effective and the date as of which it is
expected that holders of Common Stock of record shall be entitled to exchange
their shares of Common Stock for securities or other property, if any.

            3.6 DELISTING OF COMMON STOCK. If at any time after the Definitive
Agreement Date and prior to the Expiration Date or the exercise of this Warrant,
the Company's Common Stock is delisted from The Nasdaq National Market, then the
then-existing Stock Purchase Price shall be reduced, as of the opening of
business on the first business day immediately following such delisting, to a
price equal to fifty percent (50%) of the then existing Stock Purchase Price
without, solely for the purposes of this Section 3.6, any concomitant increase
in the number of shares of Common Stock for which such Warrant is then
exercisable.

      4. LISTING. The Company shall file any forms and do any acts as shall be
required from time to time to secure the listing or quotation of the Common
Stock issuable upon exercise of the Warrant with each national securities
exchange or automated quotation system, if any, upon which shares of such
securities are then listed or traded and shall use its commercially reasonable
efforts to maintain, so long as any other shares of such securities shall be so
listed or traded, such listing or quotation of all securities issued or issuable
upon the exercise of this Warrant.

      5. ISSUE TAX. The issuance of certificates for shares of Common Stock upon
the exercise of the Warrant shall be made without charge to the Holder of the
Warrant for any issue tax (other than any applicable income taxes) in respect
thereof; provided, however, that the Company shall not be required to pay any
tax which may be payable in respect of any transfer

                                       6.
<PAGE>
involved in the issuance and delivery of any certificate in a name other than
that of the then Holder of the Warrant being exercised.

      6. CLOSING OF BOOKS. The Company will at no time close its transfer books
against the transfer of any warrant or of any shares of Common Stock issued or
issuable upon the exercise of any warrant in any manner which interferes with
the timely exercise of this Warrant.

      7. NO VOTING OR DIVIDEND RIGHTS; LIMITATION OF LIABILITY. Nothing
contained in this Warrant shall be construed as conferring upon the Holder
hereof the right to vote or to consent or to receive notice as a stockholder of
the Company or any other matters or any rights whatsoever as a stockholder of
the Company. No dividends or interest shall be payable or accrued in respect of
this Warrant or the interest represented hereby or the shares purchasable
hereunder until, and only to the extent that, this Warrant shall have been
exercised. No provisions hereof, in the absence of affirmative action by the
Holder to purchase shares of Common Stock, and no mere enumeration herein of the
rights or privileges of the Holder hereof, shall give rise to any liability of
such Holder for the Stock Purchase Price or as a stockholder of the Company,
whether such liability is asserted by the Company or by its creditors.

      8. REPRESENTATIONS OF HOLDER. Holder represents that it has all necessary
power and authority to execute and deliver this Warrant. Holder further
represents that it understands that neither this Warrant nor the shares of
Common Stock issuable upon the exercise thereof have been registered under the
Act, and are being offered pursuant to an exemption from registration contained
in the Act based in part upon Holder's representations contained in this Section
8. Holder represents that by reason of its own, or of its management's,
knowledge and experience in financial and business matters, Holder is capable of
evaluating the merits and risks of its investment in the Company and has the
capacity to protect its own interests in connection with the issuance of this
Warrant and the shares of Common Stock issuable upon the exercise thereof, and
is able to bear risk, including a complete loss, of the investment. Holder
represents that it is an "accredited investor" within the meaning set forth in
Regulation D under the Act. Holder represents that it is acquiring such
securities for its own account for investment only, and not with a view towards
their distribution.

      9. TRANSFERABILITY. This Warrant is not transferable except to an
affiliate of Holder; provided that Holder provides prior written notice of such
transfer to the Company, such transferee agrees to be bound by the obligations
hereunder, and the Company may treat such transferee as the absolute owner
hereof for any purpose and as the person entitled to exercise the rights
represented by this Warrant.

      10. RIGHTS AND OBLIGATIONS SURVIVE EXERCISE OF WARRANT. The rights and
obligations of the Company, of the Holder of this Warrant and of the holder of
shares of Common Stock issued upon exercise of this Warrant, shall survive the
exercise of this Warrant.

      11. MODIFICATION AND WAIVER. This Warrant and any provision hereof may be
changed, waived, discharged or terminated only by an instrument in writing
signed by the party against which enforcement of the same is sought.

                                       7.
<PAGE>
      12. NOTICES. Any notice, request or other document required or permitted
to be given or delivered to the Holder hereof or the Company shall be in
writing, shall refer specifically to this Warrant and shall be personally
delivered or shall be sent by certified mail or internationally recognized
overnight courier, postage prepaid, to Holder at its address as shown on the
signature page hereto or to the Company at the address indicated therefor in the
first paragraph of this Warrant or such other address as either may from time to
time provide to the other in writing. Any delivery, notice, request or other
document given in conformity with this Section 12 shall be deemed to be
effective when received by the addressee.

      13. BINDING EFFECT ON SUCCESSORS. This Warrant shall be binding upon any
corporation succeeding the Company by merger, consolidation or acquisition of
all or substantially all of the Company's assets. All of the covenants and
agreements of the Company shall inure to the benefit of the successors and
assigns of the Holder hereof.

      14. DESCRIPTIVE HEADINGS AND GOVERNING LAW. The description headings of
the several sections and paragraphs of this Warrant are inserted for convenience
only and do not constitute a part of this Warrant. This Warrant shall be
construed and enforced in accordance with, and the rights of the parties shall
be governed by, the laws of the State of California.

      15. LOST WARRANTS. The Company represents and warrants to the Holder
hereof that upon receipt of evidence reasonably satisfactory to the Company of
the loss, theft, destruction, or mutilation of this Warrant and, in the case of
any such loss, theft or destruction, upon receipt of an indemnity reasonably
satisfactory to the Company, or in the case of any such mutilation upon
surrender and cancellation of such Warrant, the Company, at its expense, will
make and deliver a new Warrant, of like tenor, in lieu of the lost, stolen,
destroyed or mutilated Warrant.

      16. FRACTIONAL SHARES. No fractional shares shall be issued upon exercise
of this Warrant. The Company shall, in lieu of issuing any fractional share, pay
the Holder entitled to such fraction a sum in cash equal to such fraction
multiplied by the then effective Stock Purchase Price.

                      [THIS SPACE INTENTIONALLY LEFT BLANK]

                                       8.
<PAGE>
         IN WITNESS WHEREOF, the Company has caused this Warrant to be duly
executed by its officers, thereunto duly authorized this ___ day of __________,
2003.

                                             INTRABIOTICS PHARMACEUTICALS, INC.

                                             By:
                                                _______________________________
                                                 Eric H. Bjerkholt
                                                 Senior Vice President and Chief
                                                 Financial Officer

HOLDER:

_____________________________________________________
Print Entity Name, if applicable

By:__________________________________________________

Print Name:__________________________________________

Title:_______________________________________________

Address: ____________________________________________

         ____________________________________________
<PAGE>
                                SUBSCRIPTION FORM

                                                  Date:  _________________, 200_

IntraBiotics Pharmaceuticals, Inc.
1255 Terra Bella Avenue
Mountain View, CA  94043
Attn:  Chief Financial Officer

Ladies and Gentlemen:

[ ]      The undersigned hereby elects to exercise the warrant issued to it by
         IntraBiotics Pharmaceuticals, Inc. (the "Company") and dated
         _______________, 2003 Warrant No. CW-___ (the "Warrant") and to
         purchase thereunder __________________________________ shares of the
         Common Stock of the Company (the "Shares") at a purchase price of $____
         per Share or an aggregate purchase price of ________________ Dollars
         ($__________) (the "Purchase Price").

[ ]      The undersigned hereby elects to convert ______________________
         percent (___%) of the value of the Warrant pursuant to the provisions
         of Section 1.2 of the Warrant.

Pursuant to the terms of the Warrant the undersigned has delivered the Purchase
Price herewith in full in cash or wire transfer.

                                  Very truly yours,

                                  ______________________________________________
                                           Print Entity Name, if applicable

                                  By:___________________________________________

                                  Print Name:___________________________________

                                  Title:________________________________________<PAGE>
                                                                    EXHIBIT 10.1

                                                         Date: February 21, 2003

To:      Tower Semiconductor Ltd.
         P.O. Box 619
         Migdal Haemek 23105
         Israel
         Fax: +972-4-654-7788
         Attention: Co-Chief Executive Officer

cc:      Yigal Arnon & Co.
         One Azrieli Center
         Tel-Aviv 67021
         Israel
         Fax: +972-3-608-7714
         Attention: David H. Schapiro, Adv.

       Re: AMENDMENT TO PAYMENT SCHEDULE OF SERIES A-5 ADDITIONAL PURCHASE
  OBLIGATIONS, WAIVER OF SERIES A-5 CONDITIONS, CONVERSION OF SERIES A-4 WAFER
                 CREDITS AND OTHER PROVISIONS (THE "AMENDMENT")

Dear Sirs,

         With regard to the obligation of each party to this letter (a "Party")
to exercise the Series A-5 Additional Purchase Obligations, as provided for in
its Fab 2 Investment Agreements, as amended through the date hereof, all
capitalized terms not defined herein shall be as defined therein, each Party
hereby agrees that its agreements shall be amended as follows:

         1.       EXERCISE OF SERIES A-5 ADDITIONAL PURCHASE OBLIGATION.

         1.1.     FIRST INSTALLMENT. Each Party hereby notifies Tower
                  Semiconductor Ltd. (the "Company" or "Tower") that in
                  accordance with the terms set forth hereunder, and subject to
                  and effective upon Tower obtaining all required approvals as
                  specified in Section 7 hereof, it shall irrevocably exercise
                  sixty percent (60%) of the Series A-5 Additional Purchase
                  Obligation (the "First Installment"), which is the amount
                  identified as the First Installment with respect to such Party
                  as set forth in Exhibit A hereto, without regard to whether
                  the Series A-5 Mandatory Exercise Event occurs or whether any
                  of the conditions to a Mandatory Exercise are satisfied. The
                  First Installment shall be paid no later than five (5)
                  business days following satisfaction of the condition
                  specified in the first sentence above as evidenced by a
                  certificate delivered to each of the parties and executed by
                  Tower's CEO(s) certifying the satisfaction of such condition.

         1.2.     SECOND INSTALLMENT. Provided the conditions of Section 1.1 are
                  met, each Party hereby further notifies the Company that in
                  accordance with the terms set forth hereunder, and subject to
                  and conditioned upon the completion of the Minimum Financing
                  (as defined below), it shall irrevocably exercise forty
                  percent (40%) of the Series A-5 Additional Purchase Obligation
                  (the "Second Installment"; the First Installment and the
                  Second Installment shall collectively be referred to as the

<PAGE>

                  "Series A-5 APO Installments"), which is the amount identified
                  as the Second Installment with respect to such Party as set
                  forth in Exhibit A hereto, without regard to whether the
                  Series A-5 Mandatory Exercise Event occurs or whether any of
                  the conditions to a Mandatory Exercise are satisfied. The term
                  Minimum Financing shall mean the Raising (as defined below) by
                  the Company of the dollar amount equal to $22,105,730. The
                  term Raising shall mean the receipt of proceeds from (i) the
                  sale, in a public or private offering, of ordinary shares of
                  the Company or debt convertible into ordinary shares of the
                  Company; or (ii) any other form of fund raising which
                  satisfies the requirements for additional financing pursuant
                  to section 16.27.2 of the Facility Agreement, as amended, to
                  which the Company is a party. The Second Installment shall be
                  paid upon satisfaction of the condition specified in the first
                  sentence above as evidenced by a certificate delivered to each
                  of the parties and executed by Tower's CEO(s) certifying the
                  satisfaction of such condition; provided, further, that the
                  Second Installment shall not be due before the later of (i)
                  August 1, 2003, and (ii) five (5) business days following the
                  date upon which the Company has completed the Minimum
                  Financing. Notwithstanding the preceding sentence, the
                  obligation to advance the Second Installment shall terminate,
                  and there shall be no further obligation or liability to pay
                  the Second Installment, if the Minimum Financing shall not
                  have been completed by December 31, 2003.

                  For the avoidance of all doubt and notwithstanding the
                  provisions set forth in Sections 5 and 6 of the Additional
                  Purchase Obligation Agreement between SanDisk Corp. and Tower
                  dated July 4, 2000 or the Additional Purchase Obligation
                  Agreement between Israel Corporation Technologies (ICTech)
                  Ltd. and Tower dated December 12, 2000 or the Additional
                  Purchase Obligation Agreement between The Challenge Fund-Etgar
                  II, LP and Tower dated February 11, 2001 and as incorporated
                  by reference in all of the other Fab 2 Investment Agreements,
                  as applicable to each Party, each Party's undertaking to pay
                  the First Installment and the Second Installment is, upon
                  satisfaction of all of the conditions specified in this
                  Amendment and subject to the last sentence of the first
                  paragraph of this Section 1.2, completely irrevocable.

         2.       SHARE ISSUANCES. Immediately following the advancement of the
                  First Installment, each Party will be issued fully-paid and
                  non-assessable ordinary shares of Tower equivalent to the
                  aggregate of the First Installment divided by the average
                  trading price for the ordinary shares of the Company during
                  the thirty (30) consecutive trading days preceding the date
                  that this Amendment is approved by the Board of Directors of
                  the Company. Immediately following the advancement of the
                  Second Installment, each Party will be issued fully-paid and
                  non-assessable ordinary shares of Tower equivalent to the
                  Second Installment divided by the price per ordinary share of
                  the Company paid in connection with the Minimum Financing (the
                  "Minimum Financing Price"); provided, however, that if the
                  Minimum Financing Price cannot reasonably be calculated from
                  the documents evidencing the Minimum Financing, then the
                  Minimum Financing Price shall be

<PAGE>

                  the average trading price for the ordinary shares of the
                  Company during the thirty (30) consecutive trading days
                  preceding the date the Second Installment is paid.

         3.       CONVERSION OF PORTION OF PRE-PAID CREDIT ACCOUNT. Tower hereby
                  grants to each Party who is either SanDisk Corp. ("SNDK"),
                  Alliance Semiconductor Corp. ("ALSC"), Macronix International
                  Co., Ltd. ("MXIC") or QuickLogic Corp. ("QUIK") (SNDK, ALSC,
                  MXIC and QUIK shall each be referred to as a "Wafer Partner"
                  and collectively shall be referred as the "Wafer Partners") an
                  option to convert a number of credits equal to the number of
                  credits in each of its respective Pre-Paid Wafer Accounts that
                  were issued in connection with its advancement of the Series
                  A-4 Additional Purchase Obligation payment in October 2002 and
                  that are held in its Pre-Paid Wafer Account on December 31,
                  2005 (the "Series A-4 Credits") into fully-paid and
                  non-assessable ordinary shares of Tower equivalent to the
                  amount of the Series A-4 Credits divided by the average
                  trading price for the ordinary shares of the Company during
                  the thirty (30) consecutive trading days preceding December
                  31, 2005 (the "Conversion Price"), provided that such Party
                  provides Tower advance written notice to convert all or a
                  portion of the Series A-4 Credits no earlier than December 31,
                  2005 and by no later than January 31, 2006 (the "Conversion
                  Notice"). Tower hereby agrees to issue to each Wafer Partner
                  that provides it with a Conversion Notice the ordinary shares
                  to be issued in connection with its exercise of the Series A-4
                  Credits promptly after its receipt of such Conversion Notice.

         4.       RIGHTS OFFERING. To the extent that any of the Wafer Partners
                  shall convert their "Series A-4 Credits" into fully-paid and
                  non-assessable ordinary shares pursuant to paragraph 3, and
                  provided that such amount of converted Series A-4 Credits are
                  equivalent to or greater than an aggregate of 5% of Tower's
                  then outstanding share capital, Tower hereby undertakes to
                  prepare and file a registration statement, within a reasonable
                  time following the issuance of the ordinary shares to the
                  Wafer Partners in connection with their conversion of the
                  Series A-4 Credits, for the distribution of rights to all of
                  Tower's shareholders other than Wafer Partners but including
                  each of the Parties who are either Israel Corporation
                  Technologies (ICTech) Ltd. ("ICTech") or The Challenge
                  Fund-Etgar II, LP ("CF") (ICTech and CF shall each be referred
                  to as an "Equity Partner"), to purchase additional shares in
                  Tower at the Conversion Price to maintain their percentage of
                  ordinary shares held in Tower immediately prior to the
                  conversion of the Series A-4 Credits. Tower shall use its
                  reasonable best efforts to cause the registration statement to
                  be declared effective by the Securities and Exchange
                  Commission and the Israel Securities Authority as soon as
                  reasonably practicable after filing thereof with the
                  Securities and Exchange Commission and the Israel Securities
                  Authority.

         5.       TERMINATION OF WAFER PARTNER DIFFERENTIAL CONDITION. Upon
                  satisfaction of the condition set forth in the first sentence
                  of Section 1.1, the parties shall irrevocably agree to fully
                  and indefinitely waive

<PAGE>

                  Tower's obligation to raise an additional $50 million from
                  additional wafer partners in connection with the provisions
                  set forth in the Fab 2 Investment Agreements and related
                  letters with respect to the Wafer Partner Differential.

         6.       RESTRICTION ON TRANSFER OF EQUITY SECURITIES UNDER THE
                  CONSOLIDATED SHAREHOLDERS AGREEMENT; REGISTRATION RIGHTS. All
                  of the parties to the Consolidated Shareholders Agreement
                  dated January 18, 2001 by and between SanDisk, Alliance,
                  Macronix and Israel Corporation Ltd. (the "CSA"), hereby agree
                  that all of the ordinary shares in Tower to be issued to such
                  parties with respect to the Series A-5 Additional Purchase
                  Obligations will be subject to the restrictions on transfer of
                  Equity Securities during the Initial Restricted Period and the
                  Subsequent Restricted Period (all capitalized terms in this
                  section as defined in the CSA). All shares issued or
                  contemplated to be issued to the parties pursuant to Sections
                  2 and 3 of this Amendment shall be deemed to be Purchaser
                  Group Registrable Securities as defined in and as provided for
                  in the Registration Rights Agreement made as of January 18,
                  2001, by and among Tower Semiconductor Ltd., SanDisk
                  Corporation, Alliance Semiconductor Corp., Macronix
                  International Co., Ltd, QuickLogic Corporation and The Israel
                  Corporation Ltd.

         7.       APPROVALS. This Amendment and the parties obligations
                  hereunder are subject to and shall only become effective upon
                  the approval of the Company's audit committee, its board of
                  directors (which approval shall include the unanimous vote of
                  approval of its independent directors), its shareholders, the
                  Office of the Chief Scientist, the Investment Center and, to
                  the extent applicable, the Israel Land Administration.

         8.       FAB 2 INVESTMENT AGREEMENTS. Except as expressly set forth in
                  this Amendment and effective upon payment of the First
                  Installment in full, the Company hereby irrevocably waives,
                  forever excuses and releases the Wafer Partners and their
                  respective officers, directors and employees, from their
                  obligation to exercise the Series A-5 Additional Purchase
                  Obligation as provided for in the Fab 2 Investment Agreements,
                  including without limitation, the Additional Purchase
                  Obligation Agreement. All other provisions of the Parties' Fab
                  2 Investment Agreements shall remain unchanged.

                     [end of page intentionally left blank]

<PAGE>

         IN WITNESS WHEREOF, the parties have executed this Amendment as of the
date first above written.

/s/ Rafi Levin                           /s/ Udi Hillman
---------------------------------        ---------------------------------------
      TOWER SEMICONDUCTOR LTD.                ISRAEL CORPORATION TECHNOLOGIES
                                                    (ICTECH) LTD.

                                         By: Udi Hillman
By: Rafi Levin                               -----------------------------------
    -----------------------------        Title: CFO
Title: Co-CEO                                   --------------------------------

/s/ Michael Gray                         /s/ N.D. Reddy
---------------------------------        ---------------------------------------
      SANDISK CORPORATION                  ALLIANCE SEMICONDUCTOR CORPORATION

By: Michael Gray                         By: N.D. Reddy
   ------------------------------            -----------------------------------
Title: CFO                               Title: CEO
       --------------------------               --------------------------------

/s/ Miin C. Wu
---------------------------------         --------------------------------------
      MACRONIX (BVI) CO., LTD.                    QUICKLOGIC CORP.

By:    Miin C. Wu                         By:
   ------------------------------            -----------------------------------
Title: Director                           Title:
       --------------------------               --------------------------------

/s/ I. Ciechanover
---------------------------------
  THE CHALLENGE FUND-ETGAR II, LP

By: I. Ciechanover
    -----------------------------
Title: President
       --------------------------

<PAGE>

                                    EXHIBIT A

<TABLE>
<CAPTION>
---------------------------------------------------------------------------------
WAFER PARTNER OR EQUITY PARTNER                   FIRST               SECOND
                                                  INSTALLMENT         INSTALLMENT

---------------------------------------------------------------------------------
<S>                                               <C>                 <C>
SanDisk Corp.                                     $6,600,420          $4,400,280
Alliance Semiconductor Corp.                      $6,600,420          $4,400,280
Macronix International Co., Ltd.                  $6,600,420          $4,400,280
QuickLogic Corp.                                  $2,200,140          $1,466,760
Israel Corporation Technologies (ICTech) Ltd.     $4,400,004          $2,933,336
The Challenge Fund-Etgar II, LP                   $440,000.40         $293,333.60
---------------------------------------------------------------------------------
</TABLE>

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00051-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00051-of-00352.parquet"}]]